116 related articles for article (PubMed ID: 29974661)
1. Microparticles Locally Deliver Active Interleukin-1 Receptor Antagonist In Vivo.
Clements AEB; Groves ER; Chamberlain CS; Vanderby R; Murphy WL
Adv Healthc Mater; 2018 Aug; 7(16):e1800263. PubMed ID: 29974661
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury.
Chamberlain CS; Leiferman EM; Frisch KE; Duenwald-Kuehl SE; Brickson SL; Murphy WL; Baer GS; Vanderby R
Connect Tissue Res; 2014 Jun; 55(3):177-86. PubMed ID: 24649870
[TBL] [Abstract][Full Text] [Related]
3. Interleukin expression after injury and the effects of interleukin-1 receptor antagonist.
Chamberlain CS; Leiferman EM; Frisch KE; Brickson SL; Murphy WL; Baer GS; Vanderby R
PLoS One; 2013; 8(8):e71631. PubMed ID: 23936523
[TBL] [Abstract][Full Text] [Related]
4. Injectable biomaterials for delivery of interleukin-1 receptor antagonist: Toward improving its therapeutic effect.
Clements AEB; Murphy WL
Acta Biomater; 2019 Jul; 93():123-134. PubMed ID: 31029831
[TBL] [Abstract][Full Text] [Related]
5. Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins.
Whitmire RE; Wilson DS; Singh A; Levenston ME; Murthy N; García AJ
Biomaterials; 2012 Oct; 33(30):7665-75. PubMed ID: 22818981
[TBL] [Abstract][Full Text] [Related]
6. Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials.
Akash MS; Rehman K; Li N; Gao JQ; Sun H; Chen S
Pharm Res; 2012 Dec; 29(12):3475-85. PubMed ID: 22907416
[TBL] [Abstract][Full Text] [Related]
7. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury.
Harada H; Wakabayashi G; Takayanagi A; Shimazu M; Matsumoto K; Obara H; Shimizu N; Kitajima M
Transplantation; 2002 Nov; 74(10):1434-41. PubMed ID: 12451245
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.
Klueh U; Antar O; Qiao Y; Kreutzer DL
J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180
[TBL] [Abstract][Full Text] [Related]
9. Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament Healing.
Saether EE; Chamberlain CS; Aktas E; Leiferman EM; Brickson SL; Vanderby R
Stem Cell Rev Rep; 2016 Feb; 12(1):42-53. PubMed ID: 26530282
[TBL] [Abstract][Full Text] [Related]
10. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.
Yamada J; Dana MR; Sotozono C; Kinoshita S
Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803
[TBL] [Abstract][Full Text] [Related]
11. Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats.
Akash MS; Rehman K; Sun H; Chen S
PLoS One; 2013; 8(2):e55925. PubMed ID: 23409091
[TBL] [Abstract][Full Text] [Related]
12. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
13. IL-1Ra and its delivery strategies: inserting the association in perspective.
Akash MS; Rehman K; Chen S
Pharm Res; 2013 Nov; 30(11):2951-66. PubMed ID: 23794040
[TBL] [Abstract][Full Text] [Related]
14. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury.
Zhu J; Huang J; Dai D; Wang X; Gao J; Han W; Zhang R
Biomed Pharmacother; 2019 Mar; 111():1-5. PubMed ID: 30551029
[TBL] [Abstract][Full Text] [Related]
16. Alginate/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model.
Cao J; Cheng J; Xi S; Qi X; Shen S; Ge Y
Eur J Pharm Biopharm; 2019 Apr; 137():112-121. PubMed ID: 30779979
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
[TBL] [Abstract][Full Text] [Related]
18. A novel IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation.
Zhang DD; Zou MJ; Zhang YT; Fu WL; Xu T; Wang JX; Xia WR; Huang ZG; Gan XD; Zhu XM; Xu DG
Exp Neurol; 2017 Nov; 297():1-13. PubMed ID: 28602833
[TBL] [Abstract][Full Text] [Related]
19. Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.
Watson Levings RS; Smith AD; Broome TA; Rice BL; Gibbs EP; Myara DA; Hyddmark EV; Nasri E; Zarezadeh A; Levings PP; Lu Y; White ME; Dacanay EA; Foremny GB; Evans CH; Morton AJ; Winter M; Dark MJ; Nickerson DM; Colahan PT; Ghivizzani SC
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):101-112. PubMed ID: 29869535
[TBL] [Abstract][Full Text] [Related]
20. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254).
Kraus VB; Birmingham J; Stabler TV; Feng S; Taylor DC; Moorman CT; Garrett WE; Toth AP
Osteoarthritis Cartilage; 2012 Apr; 20(4):271-8. PubMed ID: 22273632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
